Kiniksa Pharmaceuticals L... (KNSA)
NASDAQ: KNSA
· Real-Time Price · USD
27.88
0.44 (1.60%)
At close: Jul 03, 2025, 2:21 PM
27.88
0.00%
After-hours: Jul 03, 2025, 02:21 PM EDT
1.60% (1D)
| Bid | 27.5 |
| Market Cap | 2.03B |
| Revenue (ttm) | 481.17M |
| Net Income (ttm) | -16.95M |
| EPS (ttm) | -0.24 |
| PE Ratio (ttm) | -116.17 |
| Forward PE | 21.67 |
| Analyst | Buy |
| Ask | 28.3 |
| Volume | 558,076 |
| Avg. Volume (20D) | 813,378 |
| Open | 27.50 |
| Previous Close | 27.44 |
| Day's Range | 27.12 - 27.92 |
| 52-Week Range | 17.82 - 30.69 |
| Beta | 0.05 |
About KNSA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KNSA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KNSA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Kiniksa Pharmaceuticals Ltd. is scheduled to release its earnings on Jul 22, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+20.54%
Kiniksa Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
8 months ago
-15.66%
Kiniksa Pharmaceuticals shares are trading lower after the company announced worse-than-expected Q3 financial results.
2 weeks ago · seekingalpha.com
Kiniksa Pharmaceuticals: Arcalyst Performs, KPL-387 Advancing FastKiniksa Pharmaceuticals has delivered strong share price performance this year thanks to a strong start to the year for Arcalyst. Medicare redesign with improved patient affordability has boosted Arca...
2 months ago · seekingalpha.com
Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2025 Earnings Call TranscriptKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA ) Q1 2025 Results Conference Call April 29, 2025 8:30 AM ET Company Participants Jonathan Kirshenbaum - Investor Relations Sanj Patel - Chairman...
